In contrast to what was observed with NF-κB inhibitors, combination of 2ME2 or Doc with BA, an activator of NF-κB, increased cell death in androgen-responsive as well as castration-resistant PC cell lines. Here, NFKB1 is linked to pachyonychia congenita.